Arcellx, Inc. Files 8-K Report
Ticker: ACLX · Form: 8-K · Filed: May 14, 2025 · CIK: 1786205
| Field | Detail |
|---|---|
| Company | Arcellx, INC. (ACLX) |
| Form Type | 8-K |
| Filed Date | May 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, reporting, corporate-filing
TL;DR
Arcellx filed an 8-K on 5/14/25. Standard reporting.
AI Summary
Arcellx, Inc. filed an 8-K on May 14, 2025, reporting other events and financial statements. The company, incorporated in Delaware with its principal executive offices in Redwood City, CA, operates in the Biological Products sector.
Why It Matters
This filing indicates routine corporate reporting and may contain updates on financial status or significant events for Arcellx, Inc.
Risk Assessment
Risk Level: low — This is a standard 8-K filing for routine corporate reporting and does not appear to contain any immediate material adverse information.
Key Players & Entities
- Arcellx, Inc. (company) — Registrant
- May 14, 2025 (date) — Date of Report
- Redwood City, CA (location) — Principal executive offices
- Delaware (location) — State of Incorporation
FAQ
What is the primary purpose of this 8-K filing for Arcellx, Inc.?
The 8-K filing is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting 'Other Events' and 'Financial Statements and Exhibits'.
When was this 8-K report filed by Arcellx, Inc.?
The report was filed on May 14, 2025.
Where are Arcellx, Inc.'s principal executive offices located?
Arcellx, Inc.'s principal executive offices are located at 800 Bridge Parkway, Redwood City, CA 94065.
What is Arcellx, Inc.'s Standard Industrial Classification (SIC) code?
Arcellx, Inc.'s SIC code is 2836, which corresponds to Biological Products (No Diagnostic Substances).
What is the state of incorporation for Arcellx, Inc.?
Arcellx, Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 14, 2025 regarding Arcellx, Inc. (ACLX).